BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34436011)

  • 21. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
    Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
    Bai X; Li S; Luo Y
    Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
    Royer-Bertrand B; Torsello M; Rimoldi D; El Zaoui I; Cisarova K; Pescini-Gobert R; Raynaud F; Zografos L; Schalenbourg A; Speiser D; Nicolas M; Vallat L; Klein R; Leyvraz S; Ciriello G; Riggi N; Moulin AP; Rivolta C
    Am J Hum Genet; 2016 Nov; 99(5):1190-1198. PubMed ID: 27745836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
    Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
    Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of genes involved in melanocyte differentiation in uveal melanoma.
    Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S
    Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma.
    Shi X; Xia S; Chu Y; Yang N; Zheng J; Chen Q; Fen Z; Jiang Y; Fang S; Lin J
    PLoS One; 2021; 16(8):e0255293. PubMed ID: 34370778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
    Robertson AG; Shih J; Yau C; Gibb EA; Oba J; Mungall KL; Hess JM; Uzunangelov V; Walter V; Danilova L; Lichtenberg TM; Kucherlapati M; Kimes PK; Tang M; Penson A; Babur O; Akbani R; Bristow CA; Hoadley KA; Iype L; Chang MT; ; Cherniack AD; Benz C; Mills GB; Verhaak RGW; Griewank KG; Felau I; Zenklusen JC; Gershenwald JE; Schoenfield L; Lazar AJ; Abdel-Rahman MH; Roman-Roman S; Stern MH; Cebulla CM; Williams MD; Jager MJ; Coupland SE; Esmaeli B; Kandoth C; Woodman SE
    Cancer Cell; 2017 Aug; 32(2):204-220.e15. PubMed ID: 28810145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
    de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
    Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
    Wan Q; Ren X; Tang J; Ma K; Deng YP
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma.
    Zhu R; Chen YT; Wang BW; You YY; Wang XH; Xie HT; Jiang FG; Zhang MC
    BMC Cancer; 2023 Feb; 23(1):146. PubMed ID: 36774490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis.
    Tang W; Shao Q; He Z; Zhang X; Li X; Wu R
    BMC Cancer; 2023 Apr; 23(1):303. PubMed ID: 37013511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
    Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
    Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BAG2 Is a Novel Prognostic Biomarker and Promising Immunotherapy Target in Uveal Melanoma.
    Li C; Shi H
    Crit Rev Eukaryot Gene Expr; 2023; 33(6):55-71. PubMed ID: 37522545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
    Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
    Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.
    Wang T; Zhang Y; Bai J; Xue Y; Peng Q
    BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma.
    Liu X; Zhang Q; Fan C; Tian J; Liu X; Li G
    PLoS One; 2019; 14(3):e0214073. PubMed ID: 30883611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.
    Lei P; Xue L; Wu Y; Zhong J
    Bioengineered; 2022; 13(7-12):15033-15044. PubMed ID: 37105900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
    Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
    Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.